Investigation of soluble forms of adhesion molecules VCAM-1 and ICAM-1 in patients with systemic lupus erythematosus;Sledování solubilních forem adhezivních molekul VCAM-1 a ICAM-1 u nemocných se systémovým lupus erythematodes

Ceska Revmatologie

Volumn 8, Issue 4, 2000, Pages 119-126

  Sudla, V ^a   Horak, P ^a   Luke, J ^a   Budikova M ^a   Faltnek, L ^a   Pospisi Z ^a   Heimanova Z ^a   Vaiekova J ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26344461342     PISSN: 12107905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Amoura Z, Piette Jch, Bach JF et al. The key role of nucleosomes in Lupus. Arthritis Rheum 1999; 42:833-843.
2. Boehme MW, Raeth U, Galle PR et al. Serum thrombo-modulin-a reliable marker of disease activity in systemic lupus erythematosus (SLE): advantage over established serological parameters to indicate disease activity. Clin Exp Immunol 2000; 119: 189-195.
3. Becvaf R, Paleckova A. Novejsi ukazatele poskozeni endotelu u difuznich onemocneni pojiva. Rheumatologia 1996; 10: 139-144.
4. Fucikova T, Tesaf V, Masek J et al. Adhezivni molekuly a cytokiny u vaskulitid. Brat Lek Listy 1995; 96: 523-527.
5. Mrowka C, Sieberth HG. Circulating adhesion molecules ICAM-1, VCAM-1 and e-selectin in systemic vasculitis: marked differences between Wegener's granulomatosis and systemic lupus erythematosus. Clin Invest 1994; 72: 762-1758
6. Springer T. Adhesion receptors of immune system. Nature 1990; 346: 425-434.
7. Osborn L, Hession C, Tizard R. Direct expression cloning of vascular cell adhesion molecule-1, a cytokin-induced endothelial protein that binds to lymphocytes. Cell 1989; 59: 1203-1211.
8. McIIale JF, Harari O, Marshall D et al. TNF-alpha and IL-1 sequentially induce endothelial ICAM-1 and VCAM-1 expression in MRL/lpr lupus-prone mice. J Immunol 1999; 163: 3993-11000
9. Tulek N, Aydintug O, Ozoran K et al. Soluble intercellular adhesion molecule-1 (sICAM-1) in patients with systemic lupus erythematosus. Clin Rheumatol 1996; 15: 47-50.
10. Pigott R. Soluble forms of E-selectin, ICAM-1 and VCAM-1 are present in the supernatants of cytokine activated cultured endothelial cells. Biochem Biophys Res Comm 1992; 287: 584-589.
11. Rothlein R, Mainolfi EA, Czajkowski M et al. A form of circulating ICAM-1 in human serum. Immunol 1991; 147:3788-3793.
12. Gjearing AJH, Newman W. Circulating adhesion molecules in disease. Immunol Today 1993; 14: 506-551.
13. Scudla V, Horak P, Faltynek L et al. Vaskuldrni inter-celularni adhezivni molekula-1 (VCAM-1) - novy ukazatel aktivity systemoveho lupus erythematodes? Vnitf Lek 1997; 43: 307-311.
14. Spronk PE, Limburg PC, Kallenberg CGM. Review. Serological markers of disease activity in systemic lupus erythematosus. Lupus 1995; 4: 86-94.
15. Yokoyama II, Takaeda M, Wada T et al. Glomemlar ICAM-1 expression related to circulating TNF-alpha in human glomerulonephritis. Nephron 1997; 76: 425-433.
16. Bencivelli W, Vitali C, Isenberg DA et al. and European Consensus Study Group for Disease Activity in SLE. Disease activity in SLE: Report of the consensus study group of the European workshop for rheumatology research. III. Development of the computerised clinical chart and its application to the comparison of different indices of disease activity. Clin Exp Rheumatol 1992; 10: 549-554.
17. Tan EM, Cohen AS, Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
18. Ikeda Y, Fujimoto T, Ameno M et al. Relationship between lupus nephritis activity and the serum level of soluble VCAM-1. Lupus 1998; 7: 347-354.
19. Tesaf V, Masek Z, Rychlik I et al. Cytokines and adhesion molecules in renal vasculitis and lupus nephritis. Nephrol Dial Transplant 1998; 13: 1662-1667.
20. Spronk PE, Bootsma II, Huitema MG. Levels of soluble VCAM-1, soluble ICAM-1 and soluble E selectin during disease exacerbation in patients with systemic lupus erythematosus: a long-term prospective study. Clin Exp Immunol 1994;92:415-421.
21. Lai KN, Leung JC, Lai KB et al. Upregulation of adhesion molecule expression on endothelial cells by anti-DNA autoantibodies in systemic lupus erythematosus. Clin Immunol Immunopathol 1996; 81: 229-238.
22. Nyberg F, Acevedo F, Stephansson E. Different patterns of soluble adhesion molecules in systemic and cutaneous lupus erythematosus. Exp Dermatol 1997; 6: 230-235.
23. Koide M, Furukawa F, Wnkita H et al. Soluble form of vascular cell adhesion molecule-1 in systemic lupus erythematosus and discoid lupus erythematosus (letter). J Dermatol Sci 1996; 12: 73-75.
24. Lloyd CM, Gonzalo JA, Salant DJ et al. Intercellular adhesion molecule-1 deficiency prolongs survival and protects against the development of pulmonary inflammation during murine lupus. J Clin Invest 1997; 100: 963-971.
25. Takasaki Y, Abe K, Tokano Y et al. The expression of LFA-1, ICAM-1, CD80 and CD86 molecules in Lupus patients: Implication for immunotherapy. Internal Medicine 1999; 38: 175-177.